NCT04624477 2025-11-28
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
University Health Network, Toronto
Active not recruiting
Clinical Trials
7 trialsNCT03271892 2025-11-26
AS-PTC
University Health Network, Toronto
Active not recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01709292 2025-10-27
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT01398085 2024-05-08
IoN
University College, London
Phase 2/3 Active not recruiting
NCT06271044 2024-02-21
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
Helsinki University Central Hospital
Phase NA Active not recruiting